3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
72
Precursor Cell Lymphoblastic Leukemia-Lymphoma
66
Lymphoma, Large B-Cell, Diffuse
53
Lymphoma, Non-Hodgkin
33
Leukemia
33
Burkitt Lymphoma
33
Lymphoma, Mantle-Cell
20
Lymphoma, Follicular
19
Recurrence
13
Lymphoma, B-Cell
13
Hodgkin Disease
13
Neoplasms
11
Lymphoma, Large-Cell, Anaplastic
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Sarcoma
9
Neuroblastoma
8
Multiple Myeloma
8
Medulloblastoma
8
Lymphoma, T-Cell, Peripheral
8
Lymphoma, T-Cell
7
Central Nervous System Neoplasms
7
Rhabdomyosarcoma
6
Leukemia, Biphenotypic, Acute
6
Lymphoma, B-Cell, Marginal Zone
5
Wilms Tumor
4
Waldenstrom Macroglobulinemia
4
Sarcoma, Ewing
4
Rhabdoid Tumor
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Lymphoma, Large-Cell, Immunoblastic
4
Interventions
Nivolumab
4
pertuzumab
2
pembrolizumab
2
durvalumab
2
Paclitaxel
2
Docetaxel
2
Capecitabine
2
ulocuplumab
1
tremelimumab
1
tazarotene
1
talazoparib
1
romiplostim
1
pexidartinib
1
pamiparib
1
onartuzumab
1
magrolimab
1
entrectinib
1
cobimetinib
1
atezolizumab
1
Sunitinib
1
Rifampin
1
Ramucirumab
1
Radiosurgery
1
N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide
1
Midazolam
1
MK-4166
1
LY3022855
1
LY2510924
1
LY-2157299
1
Itraconazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Solid Tumor
×
Vincristine
×
Clear all
No trials found.